Recent 8-K filings for OXSQ
Highest-materiality recent filing
Oxford Square Capital Q1 NAV drops to $1.32 from $1.69; net loss $25.5M
- NAV per share fell to $1.32 at March 31, 2026, from $1.69 at Dec 31, 2025, a 22% decline.
- Net investment income was $4.1M ($0.05/share) vs $5.4M ($0.07/share) in prior quarter.
-
Oxford Square Capital dismisses PwC, engages EY as independent auditor
Dismissed PwC as independent auditor and engaged EY effective May 26, 2026, approved by Board and audit committee.
-
Oxford Square Capital increases authorized shares from 100M to 300M via Articles of Amendment
Authorized shares of capital stock increased from 100M to 300M, all common stock, par value $0.01.
-
Entered into Amendment No. 1 to Amended and Restated Equity Distribution Agreement dated May 5, 2026.
-
Oxford Square Capital Q1 NAV drops to $1.32 from $1.69; net loss $25.5M
NAV per share fell to $1.32 at March 31, 2026, from $1.69 at Dec 31, 2025, a 22% decline.
-
Oxford Square NAV falls to $1.69; Q4 NII $5.4M; declares $0.035 monthly dividend
NAV per share at Dec 31, 2025 was $1.69, down 13.3% from $1.95 at Sep 30, 2025.
-
Oxford Square Q3 NAV drops to $1.95; declares $0.035/mo distributions; $25M buyback
NAV per share fell to $1.95 from $2.06 in Q2; net decrease in net assets from operations of $2.1M.
-
Oxford Square Capital elects director and ratifies auditor at annual meeting
Barry A. Osherow elected director with 15,651,247 for, 5,088,965 against, 25,443,974 broker non-votes.
-
Oxford Square Capital elects to redeem $24.8M of 6.25% Notes due 2026
Company will redeem all $24,790,750 outstanding principal of 6.25% Notes (CUSIP 69181V305; OXSQZ).
-
Oxford Square Q2 NII $5.5M ($0.08/shr); NAV falls to $2.06 from $2.09 QoQ
Total investment income $9.5M, down from $10.2M in Q1 2025 and $11.4M a year ago.
-
Oxford Square Capital issues $65M 7.75% Notes due 2030, ticker OXSQH
Issued $65M aggregate principal amount of 7.75% Notes due 2030; underwriters have option to purchase up to $9.75M additional.
-
Oxford Square Capital issues $65M of 7.75% Notes due 2030 in underwritten offering
Issuing $65.0M aggregate principal of 7.75% Notes due 2030, closing expected Aug 7, 2025.
-
Oxford Square Capital to redeem $10M of its 6.25% Notes due 2026 on July 18
Redeeming $10M of the $34.8M outstanding 6.25% Notes due 2026 (OXSQZ).
-
Oxford Square to redeem $10M of 6.25% Notes due 2026 on June 13
Partial redemption of $10M aggregate principal of $44.8M outstanding 6.25% Notes due 2026 (OXSQZ).
-
Oxford Square NAV falls to $2.09; net realized losses of $12.2M in Q1 2025
NAV per share $2.09 at Mar 31, 2025, down from $2.30 at Dec 31, 2024.
-
Oxford Square Q4 NAV $2.30, NII $0.09/share; maintains $0.035 monthly dividend
NAV per share of $2.30 at Dec 31, 2024, down from $2.35 at Sep 30, 2024.
-
Oxford Square Q3 NII $0.10/sh vs $0.13 Q2; NAV down to $2.35; distributions held at $0.105
NAV per share $2.35, down from $2.43 on June 30, 2024.
-
Oxford Square Capital Corp. annual meeting results: directors elected, auditor ratified
Jonathan H. Cohen elected director with 16,379,600 votes for, 1,671,641 withheld, 22,267,060 broker non-votes.
-
Oxford Square adds Lucid Capital Markets as sales agent under equity distribution agreement
Amended and Restated Equity Distribution Agreement dated August 16, 2024 adds Lucid Capital Markets as sales agent.
-
Oxford Square Q2 2024 NAV $2.43, NII $0.13/share; declares $0.035 monthly distributions
NAV per share $2.43 at June 30, 2024, up from $2.42 at March 31, 2024.
-
Oxford Square Capital Q1 NII $0.11/sh, NAV down to $2.42, net operating loss $1.8M
Net investment income $6.5M ($0.11/sh) vs $7.8M ($0.13/sh) in Q4 2023; total investment income $10.7M vs $12.3M.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.85 · Median 0.55 · Most common event earnings